ActoGeniX
ActoGeniX was a Belgian biopharmaceutical company based in Ghent that specialized in the development of orally active protein therapeutics. The company focused on using its ActoBiotic technology platform to engineer lactic acid bacteria for the delivery of therapeutic proteins, though it was eventually acquired by Intrexon Corporation.
Brand Identity Data
HQ Country
Belgium
HQ City
Ghent
EU Headquartered
Yes
EU Manufactured
No
Stock Exchange
Private
Repair / Recycling
No
Ethical Certifications
None verified
Verified on July 22, 2026